KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $300.8 million.

  • Pacific Biosciences Of California's Shares Outstanding (Weighted Average) rose 1023.36% to $300.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $300.8 million, marking a year-over-year increase of 1023.36%. This contributed to the annual value of $274.5 million for FY2024, which is 822.42% up from last year.
  • Per Pacific Biosciences Of California's latest filing, its Shares Outstanding (Weighted Average) stood at $300.8 million for Q3 2025, which was up 1023.36% from $300.2 million recorded in Q2 2025.
  • Pacific Biosciences Of California's 5-year Shares Outstanding (Weighted Average) high stood at $300.8 million for Q3 2025, and its period low was $198.6 million during Q2 2021.
  • For the 5-year period, Pacific Biosciences Of California's Shares Outstanding (Weighted Average) averaged around $249.4 million, with its median value being $251.8 million (2023).
  • In the last 5 years, Pacific Biosciences Of California's Shares Outstanding (Weighted Average) surged by 2879.64% in 2021 and then skyrocketed by 702.51% in 2024.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Shares Outstanding (Weighted Average) stood at $204.1 million in 2021, then grew by 10.0% to $224.6 million in 2022, then increased by 12.95% to $253.6 million in 2023, then increased by 8.22% to $274.5 million in 2024, then rose by 9.6% to $300.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $300.8 million for Q3 2025, versus $300.2 million for Q2 2025 and $296.9 million for Q1 2025.